Search Login Register

drotrecogin alfa activated (Xigris) Summary

Description: recombiant human activated protein C

Also Known As: Xigris; Lilly brand of drotrecogin alfa activated; rhAPC

Networked: 399 relevant articles (63 outcomes, 128 trials/studies) for this Drug

Key Diseases for which drotrecogin alfa activated is Relevant

  1. Sepsis (Septicemia) : 45 outcomes 97 studies in 318 results
  2. Septic Shock (Toxic Shock Syndrome) : 10 outcomes 5 studies in 48 results
  3. Hemorrhage : 4 outcomes 15 studies in 53 results
  4. Inflammation : 4 outcomes 8 studies in 17 results
  5. Shock : 2 outcomes 4 studies in 9 results
Show All >>

Drugs Related to drotrecogin alfa activated

  1. Protein C
  2. drotrecogin alfa activated (Xigris)
  3. Heparin (Liquaemin)
  4. Antithrombin III
  5. Adrenal Cortex Hormones (Corticosteroids)
  6. Tifacogin
  7. lipoprotein-associated coagulation inhibitor (TFPI)
  8. fibrin fragment D (D-dimer)
  9. rho-Associated Kinases
  10. Interleukin-6 (Interleukin 6)
Show All >>

Therapies Related to drotrecogin alfa activated

  1. Intensive Care (Surgical Intensive Care)
  2. Transplants (Transplant)
  3. Resuscitation
  4. Stents
  5. Liver Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.